← Browse by Condition
Medical Condition

major depressive disorder

Total Trials
21
Recruiting Now
21
Trial Phases
Phase 4, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for major depressive disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — major depressive disorder Clinical Trials

How many clinical trials are currently recruiting for major depressive disorder?
ClinicalMetric currently tracks 21 actively recruiting clinical trials for major depressive disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 21. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for major depressive disorder?
major depressive disorder research spans Phase 2 (8 trials), Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a major depressive disorder clinical trial?
Eligibility criteria for major depressive disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
8
Phase 3
2
Phase 4
1
Top Sponsors
Mclean Hospital 2 trials
Icahn School of Medicine at Mount Sinai 2 trials
Neurocrine Biosciences 1 trial
Baylor College of Medicine 1 trial
University Hospital Tuebingen 1 trial

Recruiting Clinical Trials

NCT07105111 Phase 4
Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Enrollment
100 pts
Location
United States
Sponsor
Neurocrine Biosciences
View Trial →
NCT05487911
Recruiting
Cortical rTMS as a Treatment for Depression
Enrollment
50 pts
Location
United States
Sponsor
Baylor College of Medicine
View Trial →
NCT06410599 Phase 2
Recruiting
Pharmacologic Treatment Augmentation in Chronic Depression
Enrollment
60 pts
Location
Germany
Sponsor
University Hospital Tuebingen
View Trial →
NCT07507370
Recruiting
CARED : A Novel Rapid Treatment Paradigm for Depression
Enrollment
30 pts
Location
United States
Sponsor
University of North Carolina, ...
View Trial →
NCT05630963
Recruiting
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
Enrollment
228 pts
Location
United States
Sponsor
Mclean Hospital
View Trial →
NCT06592833 Phase 2
Recruiting
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Enrollment
60 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
View Trial →
NCT06898879
Recruiting
Enhancing Veteran-Clinical Collaboration in VA PRRCs
Enrollment
119 pts
Location
United States
Sponsor
VA Office of Research and Deve...
View Trial →
NCT06163625
Recruiting
The Impact of Working Memory and Reward Markers on DLPFC Activity in Treatment-resistant Depression
Enrollment
50 pts
Location
Canada
Sponsor
Unity Health Toronto
View Trial →
NCT06450704
Recruiting
Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders
Enrollment
124 pts
Location
Spain
Sponsor
Fundación de Investigación Bio...
View Trial →
NCT04041479 Phase 3
Recruiting
Biomarker-guided rTMS for Treatment Resistant Depression
Enrollment
348 pts
Location
United States
Sponsor
Weill Medical College of Corne...
View Trial →
NCT07493317 Phase 2
Recruiting
Neutralizing Interleukin (IL)-6
Enrollment
60 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
View Trial →
NCT06093906
Recruiting
Positive Processes and Transition to Health (PATH)
Enrollment
135 pts
Location
United States
Sponsor
Case Western Reserve Universit...
View Trial →
NCT06132178 Phase 2
Recruiting
Psilocybin rTMS for Treatment Resistant Depression
Enrollment
100 pts
Location
United States
Sponsor
University of Texas at Austin
View Trial →
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
View Trial →
NCT05786066 Phase 2
Recruiting
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Enrollment
30 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT03953014
Recruiting
Pharmacogenetics of Antidepressant-Induced Disinhibition
Enrollment
120 pts
Location
Canada
Sponsor
University of Calgary
View Trial →
NCT05570812 Phase 2
Recruiting
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
Enrollment
120 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT06698666 Phase 3
Recruiting
Efficacy of Statins Among Major Depressive Disorder
Enrollment
145 pts
Location
Egypt
Sponsor
Ain Shams University
View Trial →
NCT07594483
Recruiting
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
Enrollment
20 pts
Location
United States
Sponsor
Motif Neurotech, Inc.
View Trial →
NCT06072898 Phase 2
Recruiting
A Randomized Neuroimaging Trial of Psilocybin in Depression
Enrollment
50 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
View Trial →
NCT04788524
Recruiting
Neural Correlates of Stress and Perceived Control in Adolescent Depression
Enrollment
80 pts
Location
United States
Sponsor
Mclean Hospital
View Trial →

Related Conditions

bipolar disorder (3) treatment resistant depression (3) schizophrenia (2) schizoaffective disorder (2) mdd (2) depressive disorder (2) tardive dyskinesia (1) opioid use disorder (1) suicidality (1) delusional disorder (1) inflammatory response (1) posttraumatic stress disorder (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology